This is a common type of benign tumor that grows on nerves. It's usually a soft, firm lump under the skin, often found on the face, neck, or chest. It's a key feature of Neurofibromatosis 1.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A neurofibroma is a tumor that grows from the tissue surrounding a nerve. Most are benign, meaning they are not cancer and do not spread. Many appear as soft, rubbery bumps on or just under the skin, but a neurofibroma can form along any nerve in the body, including deep nerves in the chest, abdomen, pelvis or spine. Neurofibromas come in a few forms that matter differently. Cutaneous neurofibromas are small skin bumps that can be numerous and visible; their main burden is discomfort and appearance. Plexiform neurofibromas spread along several nerve branches and the tissue around them. They can grow large, change the shape of a face or limb, press on organs, cause pain or weaken nerve function, and they carry a small but real risk of becoming cancerous. A single neurofibroma can also turn up in someone with no other signs of a genetic condition.
Many people with neurofibromas have neurofibromatosis type 1 (NF1), a genetic condition that affects roughly 1 in 3,000 people. In NF1, a change in a gene that normally restrains cell growth allows nerve-sheath cells to multiply into tumors. About half of people with NF1 inherit it from a parent; the rest have a new gene change. A person with NF1 has a 50 percent chance of passing it to each child. In NF1, about half of people develop a plexiform neurofibroma, and some are noticed in early childhood. Skin neurofibromas can begin in childhood but mostly appear during or after the teen years and become more numerous with age. A single neurofibroma in a person without NF1 has no known trigger. Nothing a person does is known to cause neurofibromas or make them grow.
A skin neurofibroma can often be recognized on examination. A lump of uncertain type, a deep tumor, or one causing pain, numbness or weakness is usually imaged with MRI, which shows its relationship to the nerve. A biopsy or removal and examination under a microscope confirms the diagnosis when that is in doubt. Finding neurofibromas also raises the question of NF1. NF1 is diagnosed when someone has at least two recognized features, such as two or more neurofibromas or one plexiform neurofibroma, six or more flat light-brown skin patches (cafe-au-lait spots), freckling in the armpits or groin, small growths on the iris, an NF1 gene change on genetic testing or a parent with NF1. Genetic testing helps when the picture is unclear. Because NF1 affects more than the nerves, the evaluation often includes an eye exam and a broader checkup. When a known plexiform neurofibroma changes, MRI combined with a PET scan (an imaging test that highlights unusually active tissue) can help decide whether a biopsy is needed to look for cancer.
Many neurofibromas need no treatment. The decision usually rests on whether a tumor causes pain, discomfort, loss of function or distress about appearance. Skin neurofibromas can be removed by surgery, laser, electrodesiccation (destroying tissue with an electric current) or radiofrequency ablation. Removal works well for individual bumps, but new ones often keep appearing in NF1, so treatment is typically repeated over the years rather than done once. For plexiform neurofibromas, surgery is the only treatment that can potentially remove the tumor entirely. Because these tumors wrap around and through nerves without a clear border, complete removal is often not possible without damaging function, and partially removed tumors can regrow. A team experienced in NF1 usually weighs these trade-offs. When a plexiform neurofibroma in NF1 causes symptoms and cannot be fully removed, two daily oral medicines are FDA-approved: selumetinib (Koselugo), for adults and children 1 year and older, and mirdametinib (Gomekli), for adults and children 2 years and older. Both are MEK inhibitors, which block a growth signal that is overactive in NF1. In the main children's study of selumetinib, about two-thirds of children's tumors shrank by at least a fifth, usually within several months; tumors rarely disappeared. These medicines are generally taken long term, commonly cause rash, diarrhea and nausea, and require regular eye exams and heart ultrasounds because of rare effects on the retina and heart muscle. They can harm a pregnancy. Pain may need its own treatment, and people with NF1 often benefit from psychological support, particularly when tumors are visible or treatment decisions are difficult.
Most neurofibromas grow slowly or stay the same for years, and many cause no symptoms. For people with NF1, the number of skin neurofibromas usually increases through adulthood, which can affect comfort, clothing choices and how people feel about their appearance. The effects of a plexiform neurofibroma depend mostly on its size and where it sits. People with NF1 benefit from regular checkups with clinicians experienced in NF1, at which existing tumors are examined for changes. Expert guidance suggests at least yearly visits for children up to age 10, every two years for older children and at least every three years for adults, with more frequent visits when a plexiform neurofibroma is causing problems. A whole-body MRI around the transition to adulthood may be offered to measure internal tumors, since a large internal tumor load predicts a higher cancer risk. Photographs of visible tumors can help track change over time. For a single neurofibroma in a person without NF1, follow-up depends on whether it was removed and whether symptoms return; ask the treating surgeon what to watch for.
See a clinician about any new lump along a nerve, especially one that causes tingling, numbness or pain when tapped, and ask about NF1 if you or your child have several skin bumps, cafe-au-lait spots or a family history. If you have NF1 or a known neurofibroma, contact your NF1 team promptly about a tumor that is growing quickly, a lump that becomes hard within a previously soft tumor, new pain that persists, wakes you at night or is hard to control, or new weakness, numbness, or bladder, bowel, swallowing or breathing problems linked to a tumor. These changes can signal transformation into a cancer called malignant peripheral nerve sheath tumor (MPNST), which needs prompt specialist assessment and, if confirmed, surgery without delay.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Neurofibroma is like, what's helped you, or ask the community a question.